Corporate calendar for Veracyte, Inc. (VCYT): upcoming earnings dates, dividend ex-dates and payment dates, stock splits, shareholder meetings and conference calls. Plan your positions around the key catalysts.
Veracyte, Inc. operates as a diagnostics company in the United States and internationally. The company offers Afirma Genomic Sequencing Classifier for cancerous thyroid nodules; Decipher Prostate Genomic Classifiers for prostate cancer diagnosis; Decipher Bladder Genomic Classifier for bladder cancer diagnosis; Prosigna Breast Cancer Assay for breast cancer diagnosis; and Percepta Nasal Swab Test for lung cancer diagnosis.
Upcoming Earnings
| Date | EPS Est. | Revenue Est. |
|---|---|---|
| 2026-11-03 | $0.43 | $147M |
| 2026-07-30 | $0.41 | $145M |
| 2026-05-05 | $0.34 | $130M |
| 2026-02-25 | $0.41 | $136M |
| 2025-11-04 | $0.32 | $125M |
| 2025-08-06 | $0.31 | $121M |
| 2025-05-07 | $0.12 | $111M |
Price
| Price | $45.81 |
| Market Cap | $3.7B |
| Exchange | NASDAQ |
| Country | US |
Related companies: ADPT · IDYA · IRON · KNSA · LEGN
Explore sector: Healthcare · Medical - Diagnostics & Research
More sections of VCYT: Overview · Financials · Valuation · Statistics · Estimates · Technical · Ownership · News
Discover more: Weekly Radar: the S&P 500 through the Buffett and Lynch methods · Investment Academy — learn to analyze stocks